Diagnamed Holdings Corp. (DMED.CN)
Diagnamed Holdings Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.06, up 0.00% on the session, giving a market capitalisation of $5.1M. Its beta of -1.28 implies it has historically moved less than the broad market.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
Diagnamed Holdings Corp. is most often compared with the following Healthcare names: